2016 ACR/ARHP Annual Meeting

November 11-16, 2016. Washington, DC.

View by Number View by Title View Sessions

View by Date

Wednesday, November 16, 2016

9:00AM-10:30AM: Abstract Number: 3126

Computational Polarizing Microscopy: A Novel Method to Detect Birefringent Crystals Using Lens-Free on-Chip Microscopy

Metabolic and Crystal Arthropathies II: Clinical Practice

9:00AM-10:30AM: Abstract Number: 3130

Development and Pilot Testing of an Online Educational Tool for Gout Patients — Mygoutcare®

Metabolic and Crystal Arthropathies II: Clinical Practice

9:00AM-10:30AM: Abstract Number: 3141

Development of a Glucocorticoid Toxicity Index Using Multi-Criteria Decision Analysis

Quality Measures and Quality of Care II

9:00AM-10:30AM: Abstract Number: 3117

Development of Autoimmune Diseases and Genetic Predisposition in Children with Neonatal Lupus and Their Unaffected Siblings

ACR/ARHP Combined Abstract Session: Pediatric Rheumatology

9:00AM-10:30AM: Abstract Number: 3118

Differences in Disease Phenotype, Management and Outcomes of Children with Juvenile Idiopathic Arthritis throughout the World – Analysis of 8,325 Patients Enrolled in the Epoca Study

ACR/ARHP Combined Abstract Session: Pediatric Rheumatology

9:00AM-10:30AM: Abstract Number: 3168

Economic Evaluation of Damage Accrual in an International SLE Inception Cohort

Systemic Lupus Erythematosus – Clinical Aspects and Treatment V: Damage and Morbidity

9:00AM-10:30AM: Abstract Number: 3113

Evaluation of a Clinical Transition Pathway for Adolescents with Autoimmune Diseases

ACR/ARHP Combined Abstract Session: Pediatric Rheumatology

9:00AM-10:30AM: Abstract Number: 3122

Genome-Wide DNA Methylation Association Study of Hand Osteoarthritis

Genetics, Genomics and Proteomics II

9:00AM-10:30AM: Abstract Number: 3178

Heart Dysfunction in Systemic Sclerosis: Involvement of a Novel Fibrogenic Stromal Cell Subset

Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Pathogenesis, Animal Models and Genetics II

9:00AM-10:30AM: Abstract Number: 3166

HLA-B27 and Ankylosing Spondylitis Have Shared Effects on the Gut Microbiome

Spondylarthropathies Psoriatic Arthritis – Pathogenesis, Etiology II

9:00AM-10:30AM: Abstract Number: 3165

HLA-B27 Expression Is Accompanied By a Profoundly Altered IgA Response to the Intestinal Microbiota and Microbial Translocation to the Joint

Spondylarthropathies Psoriatic Arthritis – Pathogenesis, Etiology II

9:00AM-10:30AM: Abstract Number: 3124

Huntingtin Interacting Protein 1 (Hip1) Is a New Arthritis Severity Gene

Genetics, Genomics and Proteomics II

9:00AM-10:30AM: Abstract Number: 3134

Hydroxychloroquine Is Not Effective in Reducing Symptoms of Hand Osteoarthritis: Results from a Placebo-Controlled Randomised Trial

Osteoarthritis – Clinical Aspect II: Treatment and Imaging

9:00AM-10:30AM: Abstract Number: 3136

Impact of Novel Smartphone Application on Pain and Mobility in Osteoarthritis Patients Treated with Hylan G-F 20

Osteoarthritis – Clinical Aspect II: Treatment and Imaging

9:00AM-10:30AM: Abstract Number: 3142

Improving Counseling, Documentation and Adherence to Highly Effective Birth Control in Women on Teratogenic Medications at a Rural Medical Center: A Quality Improvement Initiative

Quality Measures and Quality of Care II

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].